Compare ANGO & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANGO | CGC |
|---|---|---|
| Founded | 1988 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.2M | 389.2M |
| IPO Year | 2004 | 2023 |
| Metric | ANGO | CGC |
|---|---|---|
| Price | $15.30 | $0.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 306.1K | ★ 2.7M |
| Earning Date | 04-02-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $291,010,000.00 | $12,759,000.00 |
| Revenue This Year | $9.51 | $8.27 |
| Revenue Next Year | $4.96 | $15.68 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 10.17 | N/A |
| 52 Week Low | $9.39 | $0.84 |
| 52 Week High | $16.29 | $2.38 |
| Indicator | ANGO | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 46.50 | 42.66 |
| Support Level | $14.85 | $0.91 |
| Resistance Level | $16.23 | $1.15 |
| Average True Range (ATR) | 0.51 | 0.03 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 25.00 | 23.17 |
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.